Jaye Viner
Overview
Explore the profile of Jaye Viner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
305
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haluska P, Menefee M, Plimack E, Rosenberg J, Northfelt D, LaVallee T, et al.
Clin Cancer Res
. 2014 Jul;
20(18):4747-57.
PMID: 25024259
Purpose: This phase I, multicenter, open-label, single-arm, dose-escalation, and dose-expansion study evaluated the safety, tolerability, and antitumor activity of MEDI-573 in adults with advanced solid tumors refractory to standard therapy...
2.
Gao J, Chang Y, Jallal B, Viner J
Cancer Res
. 2012 Jan;
72(1):3-12.
PMID: 22215692
Insulin-like growth factors (IGF) are polypeptide hormones with potent anabolic and mitogenic effects that regulate cell growth and differentiation. Dysregulation of the IGF axis has been well documented in the...
3.
Huang J, Morehouse C, Streicher K, Higgs B, Gao J, Czapiga M, et al.
PLoS One
. 2011 Nov;
6(10):e26177.
PMID: 22046260
Purpose: Insulin-like growth factor (IGF) signaling through human insulin receptor isoform A (IR-A) contributes to tumorigenesis and intrinsic resistance to anti-IGF1R therapy. In the present study, we (a) developed quantitative...
4.
Mutch M, Schoen R, Fleshman J, Rall C, Dry S, Seligson D, et al.
Clin Gastroenterol Hepatol
. 2009 May;
7(5):568-74.
PMID: 19418605
Background & Aims: Aberrant crypt foci (ACF) are the putative precursor of colorectal adenomas. However, there are limited data available on the prevalence and risk factors for ACF. Methods: Subjects...
5.
Hawk E, Matrisian L, Nelson W, Dorfman G, Stevens L, Kwok J, et al.
Clin Cancer Res
. 2008 Jul;
14(18):5664-71.
PMID: 18612047
The Translational Research Working Group (TRWG) was created as a national initiative to evaluate the current status of the National Cancer Institute's investment in translational research and envision its future...
6.
Solomon S, Wittes J, Finn P, Fowler R, Viner J, Bertagnolli M, et al.
Circulation
. 2008 Apr;
117(16):2104-13.
PMID: 18378608
Background: Observational studies and randomized trials have reported increased cardiovascular risk associated with cyclooxygenase-2 inhibitors. Prior placebo-controlled randomized studies had limited ability to assess the relationship of either celecoxib dose...
7.
Hawk E, Viner J, Richmond E, Umar A
Cancer Chemother Biol Response Modif
. 2004 Sep;
21:759-89.
PMID: 15338773
No abstract available.
8.
Fischer S, Conti C, Viner J, Aldaz C, Lubet R
Carcinogenesis
. 2003 May;
24(5):945-52.
PMID: 12771040
The cyclooxygenase-2 (COX-2) inhibitor celecoxib and the ornithine decarboxylase (ODC) inhibitor difluoromethylornithine (DFMO) were each previously shown to prevent skin tumor development when administered throughout the course of UV irradiation....